Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 16,098 | 10,680 | 7,199 | 6,681 | 6,873 |
| Cost of Goods | 4,705 | 3,643 | 2,887 | 3,660 | 3,921 |
| Gross Profit | 11,393 | 7,037 | 4,312 | 3,021 | 2,952 |
| Operating Expenses | 53,352 | 40,742 | 33,850 | 35,807 | 34,164 |
| Operating Income | -41,254 | -33,062 | -28,651 | -32,126 | -30,291 |
| Interest Expense | 0 | 0 | 0 | -3,744 | 303 |
| Other Income | -1,064 | 5,244 | 200 | 0 | 0 |
| Pre-tax Income | -42,318 | -27,818 | -28,451 | -28,382 | -30,594 |
| Income Tax | 252 | -2 | -128 | 287 | 105 |
| Net Income Continuous | -42,570 | -27,816 | -28,323 | -28,669 | -30,699 |
| Net Income | $-42,570 | $-27,816 | $-28,323 | $-28,669 | $-30,699 |
| EPS Basic Total Ops | -1.41 | -1.12 | -1.34 | -1.38 | -1.50 |
| EPS Basic Continuous Ops | -1.41 | -1.12 | -1.34 | -1.38 | -1.50 |
| EPS Diluted Total Ops | -1.41 | -1.12 | -1.34 | -1.38 | -1.50 |
| EPS Diluted Continuous Ops | -1.41 | -1.12 | -1.34 | -1.38 | -1.50 |
| EPS Diluted Before Non-Recurring Items | -1.41 | -1.12 | -1.35 | -1.38 | -1.50 |
| EBITDA(a) | $-40,694 | $-32,126 | $-27,722 | $-30,522 | $-28,412 |